Lab21 to sell DiagnoCure's Previstage in the UK and Ireland
Executive Summary
Cancer diagnostics company DiagnoCure has granted fellow testing company Lab21 exclusive rights to sell its Previstage GCC colorectal cancer screening tool in the UK and Ireland. Testing samples will be shipped to and processed by DiagnoCure Oncology Laboratories, the US subsidiary of Canada-based DiagnoCure.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice